BillionToOne, Inc. BillionToOne, Inc.

BillionToOne, Inc.

BLLN

Classifica tra le azioni #3474
BillionToOne, Inc. is a specialized diagnostics company that innovates by... BillionToOne, Inc. is a specialized diagnostics company that innovates by precisely quantifying biological data to create advanced molecular diagnostic solutions. Central to their operations is a cutting-edge molecular counting platform, meticulously engineered to identify and measure individual DNA molecules, thereby significantly enhancing the precision of disease detection. Their product portfolio includes: UNITY Complete: A non-invasive prenatal screen that assesses a fetus's risk for aneuploidies, recessive genetic conditions, and fetal antigens, all from a simple maternal blood sample. Northstar Select: A liquid biopsy test designed to pinpoint specific mutations present in tumors, encompassing deletions, insertions, and point mutations. Northstar Response: A diagnostic tool that enables continuous tracking of cancer progression through detailed methylation assessment. Established in 2016, BillionToOne, Inc. conducts its operations from its headquarters located in Menlo Park, California.
Prezzo delle azioni
$105.11
Capitalizzazione di mercato
$4.96B
Variazione (1 giorno)
1.56%
Variazione (1 anno)
-
Paese
US
Scambia BillionToOne, Inc. (BLLN)

Categoria

Healthcare
Cronologia dei frazionamenti azionari per BillionToOne, Inc. (BLLN)
L’azione BillionToOne, Inc. (simbolo: BLLN) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Oct 21, 2026.
Una quota di BLLN acquistata prima di Oct 21, 2026 equivale oggi a 0 quote di BLLN.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti
Azienda Numero di frazionamenti azionari Moltiplicatore cumulativo Il paese
8 x34
US
7 x47
US
0 -
US
0 -
CN
1 x1
US